These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 526339)

  • 1. Effect of erythro-9-(2-hydroxy-3-nonyl) adenine on purine and pyrimidine metabolism in the human peripheral lymphocyte during the early phases of phytohemagglutinin-mediated blastogenesis.
    Skupp S; Vugrek G; Ayvazian JH
    Biochem Pharmacol; 1979 Nov; 28(22):3323-31. PubMed ID: 526339
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
    Lum CT; Sutherland DE; Najarian JS
    Clin Immunol Immunopathol; 1979 Apr; 12(4):453-9. PubMed ID: 222523
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitors of adenosine deaminase. Studies in combining high-affinity enzyme-binding structural units. erythro-1,6-Dihydro-6-(hydroxymethyl)-9-(2-hydroxy-3-nonyl)purine and erythro-9-(2-hydroxy-3-nonyl)purine.
    Woo PW; Baker DC
    J Med Chem; 1982 May; 25(5):603-5. PubMed ID: 7086847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of human lymphocyte DNA and protein synthesis in vitro by adenosine and eight modified adenine nucleosides in the presence or in the absence of adenosine deaminase inhibitors, 2'-deoxycoformycin (DCF) and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA).
    Ratech H; Kuritsky L; Thorbecke GJ; Hirschhorn R
    Cell Immunol; 1982 Apr; 68(2):244-51. PubMed ID: 6980056
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of human T-cell rosette formation by the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT; Schmidtke JR; Sutherland DE; Najarian JS
    Clin Immunol Immunopathol; 1978 Jul; 10(3):258-61. PubMed ID: 307473
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the chiral isomers of erythro- and threo-9-(2-hydroxy-3-nonyl)adenine on purine metabolism in sarcoma 180 cells.
    Chen SF; Stoeckler JD; Choi HS; Burgess FW; Marcaccio EJ; Steen PA; Berman SF; Parks RE; Panzica RP; Abushanab E
    Biochem Pharmacol; 1982 Dec; 31(24):3955-60. PubMed ID: 7159473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition.
    Bessodes M; Bastian G; Abushanab E; Panzica RP; Berman SF; Marcaccio EJ; Chen SF; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1982 Mar; 31(5):879-82. PubMed ID: 7082355
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes.
    Johnston JM; Kredich NM
    J Immunol; 1979 Jul; 123(1):97-103. PubMed ID: 448160
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenosine deaminase inhibitors. Conversion of a single chiral synthon into erythro- and threo-9-(2-hydroxy-3-nonyl)adenines.
    Bastian G; Bessodes M; Panzica RP; Abushanab E; Chen SF; Stoeckler JD; Parks RE
    J Med Chem; 1981 Dec; 24(12):1383-5. PubMed ID: 7310814
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
    J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice.
    Lambe CU; Nelson DJ
    Biochem Pharmacol; 1982 Feb; 31(4):535-9. PubMed ID: 7066021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse.
    Ballow M; Pantschenko AG
    Cell Immunol; 1981 Oct; 64(1):29-43. PubMed ID: 6975175
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of brain adenosine deaminase by 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl) adenine.
    Skolnick P; Nimitkitpaisan Y; Stalvey L; Daly JW
    J Neurochem; 1978 Jun; 30(6):1479-82. PubMed ID: 670988
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
    Plunkett W; Alexander L; Chubb S; Loo TL
    Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
    Wolberg G; Zimmerman TP
    Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
    Bluestein HG; Thompson LF; Albert DA; Seegmiller JE
    Adv Exp Med Biol; 1980; 122A():427-31. PubMed ID: 6968502
    [No Abstract]   [Full Text] [Related]  

  • 17. Niacin prevents DNA strand breakage by adenosine deaminase inhibitors.
    Weitberg AB; Corvese D
    Biochem Biophys Res Commun; 1990 Mar; 167(2):514-9. PubMed ID: 2322239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase.
    Mendelson WB; Kuruvilla A; Watlington T; Goehl K; Paul SM; Skolnick P
    Psychopharmacology (Berl); 1983; 79(2-3):126-9. PubMed ID: 6405420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
    Goday A; Simmonds HA; Webster DR; Morris GS
    Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine metabolism in adenosine deaminase deficiency.
    Mills GC; Schmalstieg FC; Trimmer KB; Goldman AS; Goldblum RM
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2867-71. PubMed ID: 1066699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.